Trademark: 88576970
Status Date
Monday, March 20, 2023
Filing Date
Tuesday, August 13, 2019
Published for Opposition
Tuesday, December 17, 2019
Abandoned Date
Monday, March 20, 2023
5 Pharmaceutical products and preparations for use in the fields of oncology, mitochondrial disease, neurodegenerative disease and antidotes
Mar 20, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 20, 2023
Abandonment - No Use Statement Filed
Jul 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 28, 2022
Sou Extension 5 Granted
Jul 21, 2022
Sou Extension 5 Filed
Jul 21, 2022
Teas Extension Received
Jan 25, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 24, 2022
Sou Extension 4 Granted
Jan 20, 2022
Sou Extension 4 Filed
Jan 20, 2022
Teas Extension Received
Jun 29, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 28, 2021
Sou Extension 3 Granted
Jun 23, 2021
Sou Extension 3 Filed
Jun 23, 2021
Teas Extension Received
Feb 4, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 3, 2021
Sou Extension 2 Granted
Jan 13, 2021
Sou Extension 2 Filed
Feb 1, 2021
Case Assigned To Intent To Use Paralegal
Jan 13, 2021
Teas Extension Received
Jul 18, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 16, 2020
Sou Extension 1 Granted
Jul 16, 2020
Sou Extension 1 Filed
Jul 16, 2020
Teas Extension Received
Feb 11, 2020
Noa E-Mailed - Sou Required From Applicant
Dec 17, 2019
Official Gazette Publication Confirmation E-Mailed
Dec 17, 2019
Published For Opposition
Nov 27, 2019
Notification Of Notice Of Publication E-Mailed
Nov 13, 2019
Approved For Pub - Principal Register
Nov 12, 2019
Assigned To Examiner
Aug 28, 2019
New Application Office Supplied Data Entered
Aug 16, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
